Europe
Germany
University hospitals with deep sub-specialisation, proton therapy and complex neurosurgery.
Country intelligence
Specialist strengths
Proton therapy · Neurosurgery · Oncology · Cardiac care · Rare disease programmes
Language support
German, English (international offices)
Travel considerations
Straightforward from the UK, Europe, Africa and the Gulf.
Visa considerations
Schengen medical visa with a hospital cost estimate and prepayment.
Connectivity
Frankfurt and Munich hubs.
Recovery environment
Rehabilitation clinics widely available.
Teleconsultation
Written second opinions are common.
Verification
University and licensed private hospitals; specialist credentials verifiable.
Advanced pathways patients ask about here
CAR-T & Cellular Therapy
Country-specific availabilityEngineered immune-cell therapies used in selected blood cancers, with eligibility decided by the treating haematology team.
Approved indications differ by country. Some programmes are only accessible inside a clinical trial.
Advanced Oncology
Established treatmentMultidisciplinary cancer care combining surgery, systemic therapy and radiotherapy.
Pathways depend on staging, pathology and prior treatment.
Precision Oncology
Established treatmentMolecular profiling used to inform targeted treatment selection by the treating oncologist.
Availability of specific targeted agents varies by regulator.
Proton Therapy
Country-specific availabilityParticle radiotherapy used in selected tumours where sparing surrounding tissue matters.
Limited number of centres worldwide; suitability is decided by radiation oncology.
Complex Cardiac Care
Established treatmentStructural heart, valve and advanced surgical cardiac programmes.
Requires current imaging and cardiology review before any planning.
Advanced Neurology
Established treatmentEpilepsy, movement disorder and neuro-oncology programmes.
Case review by a neurology team is required.
Stroke Intervention
Established treatmentTime-critical intervention and post-stroke rehabilitation pathways.
Acute stroke is an emergency — contact local emergency services first.
Bone Marrow / Stem Cell Transplantation
Established treatmentAutologous and allogeneic transplantation programmes with donor coordination.
Donor matching and eligibility are determined by the transplant centre.
Sickle Cell Treatment
Country-specific availabilityDisease-modifying therapy, transfusion programmes and curative transplant pathways.
Gene-therapy options are limited and access is strictly regulated.
Gene & Cell Therapy
Emerging / investigationalTherapies modifying or replacing cellular material in selected genetic and haematological conditions.
Frequently investigational. Never described as a cure; informed consent and regulatory status must be reviewed.
Rare Disease Programmes
Country-specific availabilitySpecialist referral centres for undiagnosed and rare conditions.
Access usually begins with a documented case review.
Clinical Trials
Clinical trialResearch studies with defined eligibility criteria, oversight and informed consent.
Participation is never guaranteed and is decided by the trial investigator.
Compare with other destinations
Healthcare decisions should be based on clinical appropriateness — not price alone. CrossCare helps patients understand their options, but diagnosis and treatment recommendations must come from qualified healthcare professionals. Estimates are for planning purposes and are not guarantees. Final pricing must be confirmed by the treating healthcare provider and relevant travel/service providers.